Cowen Trims CareMax (NASDAQ:CMAX) Target Price to $7.00

CareMax (NASDAQ:CMAXGet Rating) had its target price reduced by Cowen to $7.00 in a research report report published on Wednesday morning, Stock Target Advisor reports.

A number of other research firms also recently commented on CMAX. TheStreet downgraded CareMax from a c- rating to a d rating in a report on Tuesday, September 6th. UBS Group decreased their price target on CareMax to $11.00 in a report on Thursday, September 15th. Finally, Truist Financial started coverage on CareMax in a report on Wednesday, September 7th. They issued a hold rating and a $7.50 price target for the company.

CareMax Trading Down 0.6 %

CareMax stock opened at $4.62 on Wednesday. The company has a quick ratio of 4.78, a current ratio of 4.81 and a debt-to-equity ratio of 0.39. CareMax has a 52 week low of $3.45 and a 52 week high of $9.23. The company has a market capitalization of $403.79 million, a price-to-earnings ratio of -7.83 and a beta of 2.10. The stock has a 50-day moving average price of $6.43 and a 200 day moving average price of $6.03.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of CMAX. JPMorgan Chase & Co. lifted its holdings in CareMax by 441.0% in the first quarter. JPMorgan Chase & Co. now owns 2,125,656 shares of the company’s stock valued at $15,879,000 after acquiring an additional 1,732,736 shares during the period. Eminence Capital LP increased its position in shares of CareMax by 21.4% during the second quarter. Eminence Capital LP now owns 8,649,869 shares of the company’s stock worth $31,399,000 after purchasing an additional 1,522,755 shares in the last quarter. Vanguard Group Inc. increased its position in shares of CareMax by 95.4% during the first quarter. Vanguard Group Inc. now owns 2,915,066 shares of the company’s stock worth $21,775,000 after purchasing an additional 1,423,474 shares in the last quarter. State Street Corp increased its position in shares of CareMax by 282.1% during the second quarter. State Street Corp now owns 964,330 shares of the company’s stock worth $3,501,000 after purchasing an additional 711,941 shares in the last quarter. Finally, Citadel Advisors LLC increased its position in shares of CareMax by 345.2% during the second quarter. Citadel Advisors LLC now owns 548,726 shares of the company’s stock worth $1,992,000 after purchasing an additional 425,459 shares in the last quarter. 71.96% of the stock is owned by institutional investors and hedge funds.

About CareMax

(Get Rating)

CareMax, Inc provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States.

Featured Stories

Receive News & Ratings for CareMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareMax and related companies with MarketBeat.com's FREE daily email newsletter.